My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 109

    1.

    Effects of chromium supplementation on serum high-density lipoprotein cholesterol levels in men taking beta-blockers. A randomized, controlled trial.

    Roeback JR Jr, Hla KM, Chambless LE, Fletcher RH.

    Ann Intern Med. 1991 Dec 15;115(12):917-24.PMID: 1683196 [PubMed - indexed for MEDLINE]Related articles

    2.

    Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.

    Pasternak RC, Brown LE, Stone PH, Silverman DI, Gibson CM, Sacks FM.

    Ann Intern Med. 1996 Oct 1;125(7):529-40.PMID: 8815751 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

    Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr.

    JAMA. 1998 May 27;279(20):1615-22.PMID: 9613910 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Effect of calcium supplementation on serum cholesterol and blood pressure. A randomized, double-blind, placebo-controlled, clinical trial.

    Bostick RM, Fosdick L, Grandits GA, Grambsch P, Gross M, Louis TA.

    Arch Fam Med. 2000 Jan;9(1):31-8; discussion 39.PMID: 10664640 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients.

    Chevalier CA, Liepa G, Murphy MD, Suneson J, Vanbeber AD, Gorman MA, Cochran C.

    J Ren Nutr. 2002 Jul;12(3):183-9.PMID: 12105816 [PubMed - indexed for MEDLINE]Related articles

    6.

    A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events.

    Whitney EJ, Krasuski RA, Personius BE, Michalek JE, Maranian AM, Kolasa MW, Monick E, Brown BG, Gotto AM Jr.

    Ann Intern Med. 2005 Jan 18;142(2):95-104.PMID: 15657157 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effects of phenytoin on plasma high-density lipoprotein cholesterol levels in men with low levels of high-density lipoprotein cholesterol.

    Goerdt C, Keith M, Rubins HB.

    J Clin Pharmacol. 1995 Aug;35(8):767-75.PMID: 8522632 [PubMed - indexed for MEDLINE]Related articles

    8.

    Gemfibrozil treatment of the high triglyceride-low high-density lipoprotein cholesterol trait in men with established atherosclerosis.

    Knipscheer HC, Nurmohamed MT, Van den Ende A, Plaat B, Pruijs HJ, Mulder WJ, Kastelein JJ.

    J Intern Med. 1994 Oct;236(4):377-84.PMID: 7931040 [PubMed - indexed for MEDLINE]Related articles

    9.

    Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group.

    Grimm RH Jr, Flack JM, Grandits GA, Elmer PJ, Neaton JD, Cutler JA, Lewis C, McDonald R, Schoenberger J, Stamler J.

    JAMA. 1996 May 22-29;275(20):1549-56.PMID: 8622245 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effect of reduction of plasma triglycerides with gemfibrozil on high-density-lipoprotein-cholesterol concentrations.

    Rubins HB, Robins SJ.

    J Intern Med. 1992 Apr;231(4):421-6.PMID: 1588269 [PubMed - indexed for MEDLINE]Related articles

    11.

    Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.

    [No authors listed]

    J Am Board Fam Pract. 1991 Sep-Oct;4(5):285-97.PMID: 1746296 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effects of hormone replacement therapy on serum lipids in elderly women. a randomized, placebo-controlled trial.

    Binder EF, Williams DB, Schechtman KB, Jeffe DB, Kohrt WM.

    Ann Intern Med. 2001 May 1;134(9 Pt 1):754-60.PMID: 11329233 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Fish oil supplementation does not lower plasma cholesterol in men with hypercholesterolemia. Results of a randomized, placebo-controlled crossover study.

    Wilt TJ, Lofgren RP, Nichol KL, Schorer AE, Crespin L, Downes D, Eckfeldt J.

    Ann Intern Med. 1989 Dec 1;111(11):900-5.PMID: 2683921 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: a randomized controlled trial.

    Berthold HK, Sudhop T, von Bergmann K.

    JAMA. 1998 Jun 17;279(23):1900-2.PMID: 9634262 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.

    Guyton JR, Blazing MA, Hagar J, Kashyap ML, Knopp RH, McKenney JM, Nash DT, Nash SD.

    Arch Intern Med. 2000 Apr 24;160(8):1177-84.PMID: 10789612 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels.

    Schaefer EJ, Lamon-Fava S, Cole T, Sprecher DL, Cilla DD Jr, Balagtas CC, Rowan JP, Black DM.

    Atherosclerosis. 1996 Nov 15;127(1):113-22.PMID: 9006811 [PubMed - indexed for MEDLINE]Related articles

    17.

    Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.

    Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, Schaefer EJ, McNamara JR, Kashyap ML, Hershman JM, Wexler LF, Rubins HB; VA-HIT Study Group. Veterans Affairs High-Density Lipoprotein Intervention Trial.

    JAMA. 2001 Mar 28;285(12):1585-91.PMID: 11268266 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.

    [No authors listed]

    JAMA. 1995 Jan 18;273(3):199-208. Erratum in: JAMA 1995 Dec 6;274(21):1676. PMID: 7807658 [PubMed - indexed for MEDLINE]Related articles

    19.

    Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge? GISSI Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico).

    [No authors listed]

    Ital Heart J. 2000 Dec;1(12):810-20.PMID: 11302109 [PubMed - indexed for MEDLINE]Related articles

    20.

    Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

    Lakshman MR, Reda DJ, Materson BJ, Cushman WC, Freis ED.

    Arch Intern Med. 1999 Mar 22;159(6):551-8.PMID: 10090111 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity